BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
227 hedge funds and large institutions have $4.06B invested in Blueprint Medicines in 2019 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 70 increasing their positions, 78 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
10% less repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 78
24% less call options, than puts
Call options by funds: $42M | Put options by funds: $55.2M
50% less funds holding in top 10
Funds holding in top 10: 8 → 4 (-4)
Holders
227
Holding in Top 10
4
Calls
$42M
Puts
$55.2M
Top Buyers
| 1 | +$44M | |
| 2 | +$40.4M | |
| 3 | +$21.3M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$16.8M |
| 5 |
DM
Deerfield Management
New York
|
+$15M |
Top Sellers
| 1 | -$41.1M | |
| 2 | -$38.1M | |
| 3 | -$30.3M | |
| 4 |
HM
HealthCor Management
New York
|
-$24.1M |
| 5 |
PA
Perceptive Advisors
New York
|
-$21.2M |